Synapsoft logo
AI Insights from Disclosures
Searching...
Samyang Biopharm Corporation 0120G0
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Samyang Biopharm Corporation's business is divided into the medical devices, pharmaceuticals, and new drug development segments. The main products of the medical devices segment include biodegradable surgical sutures and absorbable hemostatic agents, and the main products of the pharmaceuticals segment include anti-cancer drugs for solid tumors and anti-cancer drugs for blood cancers.
Representative Director Kim Gyeongjin
Founded November 3, 2025
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 13111-0077896
Business number 454-87-03296
Phone Number 0221579112
Fax Number
Company Address 295 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant